Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Humana’s Q2 Earnings Beat on Cash Flow. Margins Told a Different Story.
5+ hour, 52+ min ago (249+ words) Humana stock investors are weighing a quarter that beat nearly every headline metric against a business still absorbing the cost of fixing its Medicare Advantage margins on TIKR for free → Management framed that compression as the cost of a longer…...
Elevance Health Stock Tumbles Despite Revenue Beat and Raised Full-Year Guidance
2+ week, 3+ day ago (381+ words) @Benjamas Deekam from Benjamas Deekam via Canva, @Africa images via Canva Elevance Health (ELV) stock dropped sharply on Wednesday even though the health insurer beat expectations on nearly every headline number. Adjusted earnings came in at $7.45 per share, well above…...
Morgan Stanley Raises UnitedHealth Stock Price Target Ahead of Q2 Earnings
1+ mon, 1+ day ago (433+ words) UnitedHealth (UNH) stock is getting positive attention from Wall Street ahead of its Q2 earnings report on July 16. Morgan Stanley raised its price target on the stock to $468 from $453, implying about 13% upside from recent levels, while reiterating its top-pick status. Analyst…...
Humana Stock Leads Health Insurance Rally as Wall Street Cheers Improving Margins and AI Efficiency Potential
1+ mon, 3+ week ago (327+ words) Humana (HUM) stock surged about 6%, leading a broad rally in health insurance stocks. The trigger was a wave of bullish analyst notes on the managed care sector, built around two ideas: Medical costs are moderating, and AI could unlock meaningful…...
UnitedHealth Stock Pops 5% Backed By Bank of America Upgrade to ‘Buy’
1+ mon, 3+ week ago (326+ words) UnitedHealth (UNH) stock popped nearly 6%, putting it on track for its best day since April. The spark was a fresh vote of confidence from Wall Street. Bank of America upgraded the stock to Buy from Neutral with a $450 target, and…...
Salesforce Beat Q1 Earnings by $0.76 a Share. Here’s Why the Stock Is Still Down 33% in 2026.
2+ mon, 5+ day ago (720+ words) Salesforce, Inc. (CRM) just posted a quarter that most software companies would envy. Revenue of $11.13 billion beat estimates. Non-GAAP earnings per share of $3.88 crushed the $3.12 consensus by $0.76. The company raised full-year guidance. And the stock, already down 33% year-to-date while the…...
Humana Stock Pops 11% As CMS Finalizes 2027 Medicare Advantage Rates
3+ mon, 3+ week ago (265+ words) Humana (HUM) stock surged roughly 11% after the Centers for Medicare and Medicaid Services (CMS) finalized a 2.48% rate increase for Medicare Advantage plans in 2027. The announcement also addressed a few technical changes. CMS Administrator Dr. Mehmet Oz summed it up simply:…...
Arcosa Sells Barge Business for $450M: Analysts Set a $127 Price Target
4+ mon, 3+ day ago (722+ words) Arcosa (ACA) traded at $102.85 after the infrastructure products manufacturer announced a $450 million cash sale of its barge business on February 24, reshaping its portfolio entirely around construction materials and engineered structures with record adjusted EBITDA of $583 million in FY 2025. On February…...
Centene Cuts $1 Billion in Debt as Medicaid Margins Recover: The Case for $70
4+ mon, 1+ week ago (701+ words) Medicaid managed care’s biggest turnaround story of 2026 belongs to Centene (CNC), the government-focused insurer serving 1 in 15 Americans, which swung from a $6.67 billion net loss in 2025 to guiding for adjusted EPS above $3.00 this year, trading at $34.4 against a 52-week high of…...
Elevance Health’s Medicare Crisis and $5 Billion Cash Floor: The Bull Case Explained
4+ mon, 2+ week ago (787+ words) Regulators handed Elevance Health (ELV), one of the largest U.S. health insurers and a Blue Cross Blue Shield licensee, a sanctions notice on February 27 that threatens to suspend new Medicare Advantage enrollment starting March 31, compressing shares to $292.16, near their 52-week low…...